CRISPR-Based Diagnostics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

May 2025 | 90 pages | ID: C82F70E3A22AEN
Prof Research

Abstracts

CRISPR-Based Diagnostics Market Summary

Introduction and Market Overview

CRISPR-based diagnostics leverage CRISPR-Cas systems to detect nucleic acids with high specificity and sensitivity, enabling rapid identification of pathogens, genetic mutations, and biomarkers. These diagnostics are pivotal in addressing infectious diseases, genetic disorders, and cancer, offering point-of-care (POC) solutions that require minimal equipment. The market is driven by the global burden of infectious diseases, with 10.8 million new tuberculosis cases and 39 million HIV infections in 2023, alongside the need for rapid diagnostics post-COVID-19. CRISPR’s ability to deliver results in under 30 minutes, combined with its low-cost potential, makes it ideal for low-resource settings. The aging population and rising cancer incidence, with 19.2 million new cases in 2020, further fuel demand for precise genetic diagnostics. The global CRISPR-based diagnostics market is estimated at USD 1.8-3.0 billion in 2025, with a compound annual growth rate (CAGR) of 13%-19% through 2030.

Regional Market Trends

• North America: The U.S. leads with strong investment in biotech and regulatory support, while Canada focuses on POC diagnostics for remote communities.
• Europe: Germany, France, and the UK drive growth with advanced research infrastructure, emphasizing infectious disease and cancer diagnostics.
• Asia Pacific: China and India see rapid adoption due to high infectious disease prevalence, with Japan prioritizing precision medicine applications.
• Rest of the World: Africa expands CRISPR diagnostics for tuberculosis and HIV, while Latin America invests in affordable POC solutions.

Application Analysis

• Hospitals and Clinics Diagnostic: Expected growth of 13.5%-19.5%, driven by rapid pathogen detection needs. Trends focus on POC devices for emergency diagnostics.
• Laboratories: Projected growth of 13.2%-19.2%, linked to high-throughput testing. Advances emphasize multiplexed pathogen detection.
• Pharmaceutical and Biotechnology Companies: Anticipated growth of 13.0%-19.0%, tied to drug development and companion diagnostics. Trends highlight genetic mutation screening.
• Others: Expected growth of 12.8%-18.8%, covering public health surveillance. Developments prioritize low-cost field testing.

Type Analysis

• Cas9: Expected growth of 13.3%-19.3%, valued for its precision in DNA detection. Trends focus on integration with isothermal amplification.
• Cas12: Projected growth of 13.6%-19.6%, favored for its collateral cleavage activity, ideal for POC diagnostics. Advances emphasize lateral flow readouts.
• Others: Anticipated growth of 12.9%-18.9%, covering Cas13 and novel systems. Trends highlight RNA detection for viral diagnostics.

Key Market Players

• Sherlock Biosciences: Develops rapid POC CRISPR diagnostics for infectious diseases.
• Mammoth Biosciences: Offers DETECTR platform for pathogen and mutation detection.
• CrisprBits: Focuses on affordable diagnostics for low-resource settings.
• Thermo Fisher Scientific: Provides CRISPR tools for research and diagnostics.
• Molbio Diagnostics: Integrates CRISPR with portable PCR systems.

Porter’s Five Forces Analysis

• Threat of New Entrants: Moderate, due to high R&D costs and intellectual property barriers, but open-source CRISPR tools lower entry hurdles.
• Threat of Substitutes: Moderate, with PCR and NGS competing, but CRISPR’s speed and simplicity offer advantages in POC settings.
• Bargaining Power of Buyers: Moderate, as hospitals seek cost-effective diagnostics, but specialized CRISPR applications limit options.
• Bargaining Power of Suppliers: Low, with multiple providers of reagents and enzymes.
• Competitive Rivalry: High, with players competing on speed, cost, and multiplexing capabilities.

Market Opportunities and Challenges

Opportunities:

• Addressing infectious diseases, with 10.8 million TB cases annually, using rapid CRISPR tests.
• Leveraging COVID-19-driven demand for POC diagnostics, as seen with Sherlock’s FDA-approved kits.
• Supporting cancer and genetic disease diagnostics, with 19.2 million cancer cases in 2020.
• Utilizing portable devices like DETECTR for low-resource settings.
• Aligning with WHO’s genomic strategy for standardized diagnostics.
• Attracting investment, with health tech funding up 15% from 2020-2023.

Challenges:

• High development costs for multiplexed assays.
• Regulatory delays, with FDA approvals taking 1-2 years.
• Intellectual property disputes limiting commercialization.
• Limited infrastructure in low-income regions.
• Competition from established PCR and NGS technologies.

Contents

CHAPTER 1 EXECUTIVE SUMMARY

CHAPTER 2 ABBREVIATION AND ACRONYMS

CHAPTER 3 PREFACE

3.1 Research Scope
3.2 Research Sources
  3.2.1 Data Sources
  3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users

CHAPTER 5 MARKET TREND ANALYSIS

5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats

CHAPTER 6 INDUSTRY CHAIN ANALYSIS

6.1 Upstream/Suppliers Analysis
6.2 Crispr-Based Diagnostics Analysis
  6.2.1 Technology Analysis
  6.2.2 Cost Analysis
  6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users

CHAPTER 7 LATEST MARKET DYNAMICS

7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics

CHAPTER 8 HISTORICAL AND FORECAST CRISPR-BASED DIAGNOSTICS MARKET IN NORTH AMERICA (2020-2030)

8.1 Crispr-Based Diagnostics Market Size
8.2 Crispr-Based Diagnostics Market by End Use
8.3 Competition by Players/Suppliers
8.4 Crispr-Based Diagnostics Market Size by Type
8.5 Key Countries Analysis
  8.5.1 United States
  8.5.2 Canada
  8.5.3 Mexico

CHAPTER 9 HISTORICAL AND FORECAST CRISPR-BASED DIAGNOSTICS MARKET IN SOUTH AMERICA (2020-2030)

9.1 Crispr-Based Diagnostics Market Size
9.2 Crispr-Based Diagnostics Market by End Use
9.3 Competition by Players/Suppliers
9.4 Crispr-Based Diagnostics Market Size by Type
9.5 Key Countries Analysis
  9.5.1 Brazil
  9.5.2 Argentina
  9.5.3 Chile
  9.5.4 Peru

CHAPTER 10 HISTORICAL AND FORECAST CRISPR-BASED DIAGNOSTICS MARKET IN ASIA & PACIFIC (2020-2030)

10.1 Crispr-Based Diagnostics Market Size
10.2 Crispr-Based Diagnostics Market by End Use
10.3 Competition by Players/Suppliers
10.4 Crispr-Based Diagnostics Market Size by Type
10.5 Key Countries Analysis
  10.5.1 China
  10.5.2 India
  10.5.3 Japan
  10.5.4 South Korea
  10.5.5 Southest Asia
  10.5.6 Australia

CHAPTER 11 HISTORICAL AND FORECAST CRISPR-BASED DIAGNOSTICS MARKET IN EUROPE (2020-2030)

11.1 Crispr-Based Diagnostics Market Size
11.2 Crispr-Based Diagnostics Market by End Use
11.3 Competition by Players/Suppliers
11.4 Crispr-Based Diagnostics Market Size by Type
11.5 Key Countries Analysis
  11.5.1 Germany
  11.5.2 France
  11.5.3 United Kingdom
  11.5.4 Italy
  11.5.5 Spain
  11.5.6 Belgium
  11.5.7 Netherlands
  11.5.8 Austria
  11.5.9 Poland
  11.5.10 Russia

CHAPTER 12 HISTORICAL AND FORECAST CRISPR-BASED DIAGNOSTICS MARKET IN MEA (2020-2030)

12.1 Crispr-Based Diagnostics Market Size
12.2 Crispr-Based Diagnostics Market by End Use
12.3 Competition by Players/Suppliers
12.4 Crispr-Based Diagnostics Market Size by Type
12.5 Key Countries Analysis
  12.5.1 Egypt
  12.5.2 Israel
  12.5.3 South Africa
  12.5.4 Gulf Cooperation Council Countries
  12.5.5 Turkey

CHAPTER 13 SUMMARY FOR GLOBAL CRISPR-BASED DIAGNOSTICS MARKET (2020-2025)

13.1 Crispr-Based Diagnostics Market Size
13.2 Crispr-Based Diagnostics Market by End Use
13.3 Competition by Players/Suppliers
13.4 Crispr-Based Diagnostics Market Size by Type

CHAPTER 14 GLOBAL CRISPR-BASED DIAGNOSTICS MARKET FORECAST (2025-2030)

14.1 Crispr-Based Diagnostics Market Size Forecast
14.2 Crispr-Based Diagnostics Application Forecast
14.3 Competition by Players/Suppliers
14.4 Crispr-Based Diagnostics Type Forecast

CHAPTER 15 ANALYSIS OF GLOBAL KEY VENDORS

15.1 Sherlock Biosciences
  15.1.1 Company Profile
  15.1.2 Main Business and CRISPR-Based Diagnostics Information
  15.1.3 SWOT Analysis of Sherlock Biosciences
  15.1.4 Sherlock Biosciences CRISPR-Based Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
15.2 Mammoth Biosciences
  15.2.1 Company Profile
  15.2.2 Main Business and CRISPR-Based Diagnostics Information
  15.2.3 SWOT Analysis of Mammoth Biosciences
  15.2.4 Mammoth Biosciences CRISPR-Based Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
15.3 CrisprBits
  15.3.1 Company Profile
  15.3.2 Main Business and CRISPR-Based Diagnostics Information
  15.3.3 SWOT Analysis of CrisprBits
  15.3.4 CrisprBits CRISPR-Based Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
15.4 Thermo Fisher Scientific
  15.4.1 Company Profile
  15.4.2 Main Business and CRISPR-Based Diagnostics Information
  15.4.3 SWOT Analysis of Thermo Fisher Scientific
  15.4.4 Thermo Fisher Scientific CRISPR-Based Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
15.5 Molbio Diagnostics
  15.5.1 Company Profile
  15.5.2 Main Business and CRISPR-Based Diagnostics Information
  15.5.3 SWOT Analysis of Molbio Diagnostics
  15.5.4 Molbio Diagnostics CRISPR-Based Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
15.6 Horizon Discovery
  15.6.1 Company Profile
  15.6.2 Main Business and CRISPR-Based Diagnostics Information
  15.6.3 SWOT Analysis of Horizon Discovery
  15.6.4 Horizon Discovery CRISPR-Based Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
Please ask for sample pages for full companies list
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Crispr-Based Diagnostics Report
Table Data Sources of Crispr-Based Diagnostics Report
Table Major Assumptions of Crispr-Based Diagnostics Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Crispr-Based Diagnostics Picture
Table Crispr-Based Diagnostics Classification
Table Crispr-Based Diagnostics Applications
Table Drivers of Crispr-Based Diagnostics Market
Table Restraints of Crispr-Based Diagnostics Market
Table Opportunities of Crispr-Based Diagnostics Market
Table Threats of Crispr-Based Diagnostics Market
Table Covid-19 Impact For Crispr-Based Diagnostics Market
Table Raw Materials Suppliers
Table Different Production Methods of Crispr-Based Diagnostics
Table Cost Structure Analysis of Crispr-Based Diagnostics
Table Key End Users
Table Latest News of Crispr-Based Diagnostics Market
Table Merger and Acquisition
Table Planned/Future Project of Crispr-Based Diagnostics Market
Table Policy of Crispr-Based Diagnostics Market
Table 2020-2030 North America Crispr-Based Diagnostics Market Size
Figure 2020-2030 North America Crispr-Based Diagnostics Market Size and CAGR
Table 2020-2030 North America Crispr-Based Diagnostics Market Size by Application
Table 2020-2025 North America Crispr-Based Diagnostics Key Players Revenue
Table 2020-2025 North America Crispr-Based Diagnostics Key Players Market Share
Table 2020-2030 North America Crispr-Based Diagnostics Market Size by Type
Table 2020-2030 United States Crispr-Based Diagnostics Market Size
Table 2020-2030 Canada Crispr-Based Diagnostics Market Size
Table 2020-2030 Mexico Crispr-Based Diagnostics Market Size
Table 2020-2030 South America Crispr-Based Diagnostics Market Size
Figure 2020-2030 South America Crispr-Based Diagnostics Market Size and CAGR
Table 2020-2030 South America Crispr-Based Diagnostics Market Size by Application
Table 2020-2025 South America Crispr-Based Diagnostics Key Players Revenue
Table 2020-2025 South America Crispr-Based Diagnostics Key Players Market Share
Table 2020-2030 South America Crispr-Based Diagnostics Market Size by Type
Table 2020-2030 Brazil Crispr-Based Diagnostics Market Size
Table 2020-2030 Argentina Crispr-Based Diagnostics Market Size
Table 2020-2030 Chile Crispr-Based Diagnostics Market Size
Table 2020-2030 Peru Crispr-Based Diagnostics Market Size
Table 2020-2030 Asia & Pacific Crispr-Based Diagnostics Market Size
Figure 2020-2030 Asia & Pacific Crispr-Based Diagnostics Market Size and CAGR
Table 2020-2030 Asia & Pacific Crispr-Based Diagnostics Market Size by Application
Table 2020-2025 Asia & Pacific Crispr-Based Diagnostics Key Players Revenue
Table 2020-2025 Asia & Pacific Crispr-Based Diagnostics Key Players Market Share
Table 2020-2030 Asia & Pacific Crispr-Based Diagnostics Market Size by Type
Table 2020-2030 China Crispr-Based Diagnostics Market Size
Table 2020-2030 India Crispr-Based Diagnostics Market Size
Table 2020-2030 Japan Crispr-Based Diagnostics Market Size
Table 2020-2030 South Korea Crispr-Based Diagnostics Market Size
Table 2020-2030 Southeast Asia Crispr-Based Diagnostics Market Size
Table 2020-2030 Australia Crispr-Based Diagnostics Market Size
Table 2020-2030 Europe Crispr-Based Diagnostics Market Size
Figure 2020-2030 Europe Crispr-Based Diagnostics Market Size and CAGR
Table 2020-2030 Europe Crispr-Based Diagnostics Market Size by Application
Table 2020-2025 Europe Crispr-Based Diagnostics Key Players Revenue
Table 2020-2025 Europe Crispr-Based Diagnostics Key Players Market Share
Table 2020-2030 Europe Crispr-Based Diagnostics Market Size by Type
Table 2020-2030 Germany Crispr-Based Diagnostics Market Size
Table 2020-2030 France Crispr-Based Diagnostics Market Size
Table 2020-2030 United Kingdom Crispr-Based Diagnostics Market Size
Table 2020-2030 Italy Crispr-Based Diagnostics Market Size
Table 2020-2030 Spain Crispr-Based Diagnostics Market Size
Table 2020-2030 Belgium Crispr-Based Diagnostics Market Size
Table 2020-2030 Netherlands Crispr-Based Diagnostics Market Size
Table 2020-2030 Austria Crispr-Based Diagnostics Market Size
Table 2020-2030 Poland Crispr-Based Diagnostics Market Size
Table 2020-2030 Russia Crispr-Based Diagnostics Market Size
Table 2020-2030 MEA Crispr-Based Diagnostics Market Size
Figure 2020-2030 MEA Crispr-Based Diagnostics Market Size and CAGR
Table 2020-2030 MEA Crispr-Based Diagnostics Market Size by Application
Table 2020-2025 MEA Crispr-Based Diagnostics Key Players Revenue
Table 2020-2025 MEA Crispr-Based Diagnostics Key Players Market Share
Table 2020-2030 MEA Crispr-Based Diagnostics Market Size by Type
Table 2020-2030 Egypt Crispr-Based Diagnostics Market Size
Table 2020-2030 Israel Crispr-Based Diagnostics Market Size
Table 2020-2030 South Africa Crispr-Based Diagnostics Market Size
Table 2020-2030 Gulf Cooperation Council Countries Crispr-Based Diagnostics Market Size
Table 2020-2030 Turkey Crispr-Based Diagnostics Market Size
Table 2020-2025 Global Crispr-Based Diagnostics Market Size by Region
Table 2020-2025 Global Crispr-Based Diagnostics Market Size Share by Region
Table 2020-2025 Global Crispr-Based Diagnostics Market Size by Application
Table 2020-2025 Global Crispr-Based Diagnostics Market Share by Application
Table 2020-2025 Global Crispr-Based Diagnostics Key Vendors Revenue
Figure 2020-2025 Global Crispr-Based Diagnostics Market Size and Growth Rate
Table 2020-2025 Global Crispr-Based Diagnostics Key Vendors Market Share
Table 2020-2025 Global Crispr-Based Diagnostics Market Size by Type
Table 2020-2025 Global Crispr-Based Diagnostics Market Share by Type
Table 2025-2030 Global Crispr-Based Diagnostics Market Size by Region
Table 2025-2030 Global Crispr-Based Diagnostics Market Size Share by Region
Table 2025-2030 Global Crispr-Based Diagnostics Market Size by Application
Table 2025-2030 Global Crispr-Based Diagnostics Market Share by Application
Table 2025-2030 Global Crispr-Based Diagnostics Key Vendors Revenue
Figure 2025-2030 Global Crispr-Based Diagnostics Market Size and Growth Rate
Table 2025-2030 Global Crispr-Based Diagnostics Key Vendors Market Share
Table 2025-2030 Global Crispr-Based Diagnostics Market Size by Type
Table 2025-2030 Crispr-Based Diagnostics Global Market Share by Type